Needle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: August 08, 2023 Report Code: GDME1593EPD-ST

Select Item

Needle Free Injections Pipeline Market Report Overview

Needle free Injections are devices that do not use a needle to administer medication. The Needle Free Injections pipeline market research report provides comprehensive information about the Needle Free Injections pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       Mexico

·       The UK

·       Canada

·       Costa Rica

·       El Salvador
Key Regulatory Paths ·       510(k)

·       CE

·       MDL
Leading Companies ·       Boston Scientific Corp

·       Crossject SA

·       Enable Injections Inc

·       Enesi Pharma Ltd

·       Eternity Healthcare Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Needle Free Injections Pipeline Market Segmentation by Territories

Some of the key territories in the needle free injections market are the US, Europe, Mexico, the UK, Canada, Costa Rica, and El Salvador. As of August 2023, the US has the highest number of pipeline products.

Needle Free Injections Pipeline Market Analysis by Territories, 2023 (%)

Needle Free Injections Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Needle Free Injections pipeline market, download a free report sample

Needle Free Injections Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the needle free injections pipeline market are 510(k), CE, and MDL. As of August 2023, 510(k) is the most followed pathway for pipeline products in the market.

Needle Free Injections Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Needle Free Injections Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Needle Free Injections pipeline market, download a free report sample

Needle Free Injections Pipeline Market – Competitive Landscape

Some of the key companies in the Needle Free Injections pipeline market are Boston Scientific Corp, Crossject SA, Enable Injections Inc, Enesi Pharma Ltd, and Eternity Healthcare Inc.

Boston Scientific Corp: It is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia, and Puerto Rico. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Crossject SA: It is a medical device company that develops injection systems. The company markets its products through its network of distributors in France and abroad. Crossject is headquartered in Dijon, Bourgogne-Franche-Comte, France.

Needle Free Injections Pipeline Market Analysis by Companies, 2023

Needle Free Injections Pipeline Market Analysis by Companies, 2023

For more company insights into the Needle Free Injections pipeline market, download a free report sample

Segments Covered in the Report

Needle Free Injections Pipeline Market Territories Outlook

  • The US
  • Europe
  • Mexico
  • The UK
  • Canada
  • Costa Rica
  • El Salvador

Needle Free Injections Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • MDL

Scope

This report provides:

  • Extensive coverage of the Needle Free Injections under development.

  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Needle Free Injections and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of Needle Free Injections under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Boston Scientific Corp
Crossject SA
Enable Injections Inc
Enesi Pharma Ltd
Eternity Healthcare Inc
Inovio Pharmaceuticals Inc
Medical International Technologies (Mit Canada) Inc
PharmaJet Inc
Teva Pharmaceutical Industries Ltd

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Needle Free Injections Overview

  • 3 Products under Development

    • 3.1 Needle Free Injections – Pipeline Products by Stage of Development

    • 3.2 Needle Free Injections – Pipeline Products by Territory

    • 3.3 Needle Free Injections – Pipeline Products by Regulatory Path

    • 3.4 Needle Free Injections – Pipeline Products by Estimated Approval Date

  • 4 Needle Free Injections – Pipeline Products under Development by Companies

    • 4.1 Needle Free Injections Companies – Pipeline Products by Stage of Development

    • 4.2 Needle Free Injections – Pipeline Products by Stage of Development

  • 5 Needle Free Injections Companies and Product Overview

    • 5.1 Boston Scientific Corp Company Overview

      • 5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Crossject SA Company Overview

      • 5.2.1 Crossject SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Enable Injections Inc Company Overview

      • 5.3.1 Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Enesi Pharma Ltd Company Overview

      • 5.4.1 Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Eternity Healthcare Inc Company Overview

      • 5.5.1 Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Inovio Pharmaceuticals Inc Company Overview

      • 5.6.1 Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Medical International Technologies (Mit Canada) Inc Company Overview

      • 5.7.1 Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 PharmaJet Inc Company Overview

      • 5.8.1 PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Teva Pharmaceutical Industries Ltd Company Overview

      • 5.9.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Needle Free Injections- Recent Developments

    • 6.1 Jul 28, 2023: Boston Scientific’s net income increases by 6% in Q2 2023

    • 6.2 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility

    • 6.3 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure

    • 6.4 Jul 12, 2023: Carclo Announces Unaudited Preliminary Results for the year ended 31 March 2023

    • 6.5 Jul 05, 2023: Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2

    • 6.6 Jun 15, 2023: Jabil Announces Financial Results for Q3 of Fiscal Year 2023

    • 6.7 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023

    • 6.8 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format

    • 6.9 Mar 20, 2023: Crossject Announces 2022 Annual Results

    • 6.10 Mar 03, 2023: Jabil Lays off 200 employees

    • 6.11 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results

    • 6.12 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023

    • 6.13 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022

    • 6.14 Jan 31, 2023: Daiichi Sankyo Announces Consolidated Financial Results for the First Nine Months of the Year Ending March 31,2023

    • 6.15 Jan 12, 2023: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and 2023 Financial Guidance at 8 a.m. ET on February 8, 2023

    • 6.16 Dec 01, 2022: Vaxxas Appoints Doug Cubbin as Chief Financial Officer

    • 6.17 Nov 21, 2022: Teva Announces Appointment of Richard Francis as President and CEO

    • 6.18 Nov 21, 2022: Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO

    • 6.19 Nov 15, 2022: Carclo Announces Retirement and Appointment of Chief Financial Officer

    • 6.20 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022

    • 6.21 Nov 07, 2022: Carclo Announces Nick Sanders step down as Non-Executive Chair and Director of the Company

    • 6.22 Oct 31, 2022: Daiichi Sankyo announces FY2022 Q2 Financial Results Presentation

    • 6.23 Oct 31, 2022: Daiichi Sankyo announces Consolidated Financial Results for the First Six Months of the Year Ending March 31,2023

    • 6.24 Oct 06, 2022: Carclo Appoints Frank Doorenbosch as Chief Executive Officer

    • 6.25 Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors

    • 6.26 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Needle Free Injections – Pipeline Products by Stage of Development 9

Needle Free Injections – Pipeline Products by Territory 10

Needle Free Injections – Pipeline Products by Regulatory Path 11

Needle Free Injections – Pipeline Products by Estimated Approval Date 12

Needle Free Injections Companies – Pipeline Products by Stage of Development 13

Needle Free Injections – Pipeline Products by Stage of Development 14

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15

JetTouch System – Overactive Bladder – Product Status 15

JetTouch System – Overactive Bladder – Product Description 15

Crossject SA Pipeline Products & Ongoing Clinical Trials Overview 16

Zeneo ID Human Needle-Free Injection Device – Product Status 16

Zeneo ID Human Needle-Free Injection Device – Product Description 17

Zeneo IM 0.5ml Needle-Free Injection Device – Product Status 17

Zeneo IM 0.5ml Needle-Free Injection Device – Product Description 17

Zeneo SC 0.5ml Needle-Free Injection Device – Product Status 18

Zeneo SC 0.5ml Needle-Free Injection Device – Product Description 18

Zeneo SC 0.8ml Needle-Free Injection Device – Product Status 18

Zeneo SC 0.8ml Needle-Free Injection Device – Product Description 19

Zeneo SC High Viscosity Needle-Free Injection Device – Product Status 19

Zeneo SC High Viscosity Needle-Free Injection Device – Product Description 19

Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Enable Smart enFuse – Product Status 20

Enable Smart enFuse – Product Description 21

enFuse On-Body Infusor – Product Status 21

enFuse On-Body Infusor – Product Description 21

Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Enesi ImplaVax System – Product Status 22

Enesi ImplaVax System – Product Description 23

Eternity Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Multi Channel Needle-Free Injection Device – Product Status 24

Multi Channel Needle-Free Injection Device – Product Description 24

Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Iject Pre-Filled Syringe – Product Status 25

Iject Pre-Filled Syringe – Product Description 26

Iject R Pre-Filled Syringe – Product Status 26

Iject R Pre-Filled Syringe – Product Description 26

Intradermal Pen Injector – Product Status 27

Intradermal Pen Injector – Product Description 27

Intradermal Syringe – Product Status 27

Intradermal Syringe – Product Description 28

Mega Jet – Product Status 28

Mega Jet – Product Description 28

Multi-Port Orifices – Product Status 29

Multi-Port Orifices – Product Description 29

Needle-Free Vaccine Delivery Device – Product Status 29

Needle-Free Vaccine Delivery Device – Product Description 30

Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview 31

MIT-H-IV-1 – Product Status 31

MIT-H-IV-1 – Product Description 31

MIT-H-IV-5 – Product Status 32

MIT-H-IV-5 – Product Description 32

MIT-H-VI Dental Injector – Product Status 32

MIT-H-VI Dental Injector – Product Description 33

PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Pre-filled Syringe – Product Status 34

Pre-filled Syringe – Product Description 34

Variable Volume Drug Delivery Device – Product Status 35

Variable Volume Drug Delivery Device – Product Description 35

Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

MicroDose Needlefree System – Product Status 36

MicroDose Needlefree System – Product Description 36

Glossary 58

Figures

Needle Free Injections – Pipeline Products by Stage of Development 9

Needle Free Injections – Pipeline Products by Territory 10

Needle Free Injections – Pipeline Products by Regulatory Path 11

Needle Free Injections – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Needle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Needle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Needle Free Injections reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share,…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Needle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Needle Free Injections Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more